Creative Edge Nutrition Inc(OTCMKTS:FITX) announced that it would provide additional data to Health Canada. The information will support its application that will be functional under the Federal Government Act named Medical Marijuana Purposes Regulations. Creative Edge develops nutritional supplement products to help people achieve healthy and active lifestyle.
Creative Edge Nutrition Inc(OTCMKTS:FITX) is providing all the necessary information to Health Canada to pass through the rigorous and lengthy application process. The details are must as CEN Biotech Inc. is a Canadian firm. Health Canada stated that it would not disclose details in respect to the application submitted under the MMPR. It is as per the Canada’s Privacy Act. However, in this case, key data contained in written communication was provided to the Media. CEN Biotech Inc. has approached the Office of the Privacy Commissioner to make sure that shareholders, staff, corporation and others within the MMPR remain protected under Federal Act.
Health Canada has both an obligation and a right to ask questions of the company in this program. Creative Edge Nutrition Inc(OTCMKTS:FITX) has fulfilled all of Health Canada’s requirements till this time and will continue to follow in future. It is making all the efforts to answer all the queries to Health Canada’s satisfaction. The news that will be shared with shareholders, stakeholders, public and news media will be in defined norms.
The future ahead
Creative Edge Nutrition Inc(OTCMKTS:FITX) said that prospects seem bright of CEN Biotech getting a license from Health Canada. It will be a great achievement for CEN biotech as company will get the assistance to develop a much-needed therapeutic drug, as required by the Supreme Court of Canada. Creative Edge offers various nutritional supplement including capsules, tablets and powders. It also manufactures science-based nutrition products in categories of nutrition challenges, energy, weight management and fitness, as per the GMP guidelines. Creative Edge is looking to spin off CEN in near future.